Nath Bio-Genes (India) Ltd

Nath Bio-Genes (India) Ltd

₹ 211 1.26%
11 Oct - close price
About

Incorporated in 1993, Nath Bio-Genes Ltd
is in the business of Production, Processing,
and Marketing of Hybrid and GM Seeds[1]

Key Points

Business Overview:[1][2][3]
NBGL is a flagship company of Nath Group.
It is an agri-tech company in the business of developing and supplying quality BT, hybrid, and varietal seeds to farmers at affordable prices. It does the production and processing of commercial and vegetable seeds on lands taken on lease from various growers /farmers throughout India. The company enters into seed production agreements with these farmers/growers and compensates them for various cultivation expenses based on the rate agreement entered into

  • Market Cap 401 Cr.
  • Current Price 211
  • High / Low 264 / 167
  • Stock P/E 10.6
  • Book Value 321
  • Dividend Yield 0.95 %
  • ROCE 6.77 %
  • ROE 6.14 %
  • Face Value 10.0

Pros

  • Stock is trading at 0.66 times its book value

Cons

  • Tax rate seems low

* The pros and cons are machine generated. Pros / cons are based on a checklist to highlight important points. Please exercise caution and do your own analysis.

Peer comparison

Sector: Miscellaneous Industry: Miscellaneous

Loading peers table ...

Quarterly Results

Consolidated Figures in Rs. Crores / View Standalone

Mar 2022 Jun 2022 Sep 2022 Dec 2022 Mar 2023 Jun 2023 Sep 2023 Dec 2023 Mar 2024 Jun 2024
27 209 22 25 45 235 23 32 43 244
49 175 17 20 41 198 17 26 39 207
Operating Profit -21 34 5 6 4 37 5 6 4 37
OPM % -78% 16% 22% 22% 9% 16% 23% 18% 9% 15%
-88 0 0 0 0 0 0 3 1 0
Interest 2 3 3 3 2 3 2 3 1 2
Depreciation 1 1 1 1 1 1 1 1 1 1
Profit before tax -113 31 2 2 2 34 2 5 3 34
Tax % 3% 1% 4% 34% 14% 1% 18% 17% 19% 1%
-116 31 1 1 1 33 2 4 3 33
EPS in Rs -61.21 16.19 0.77 0.71 0.76 17.59 0.85 2.02 1.38 17.55
Raw PDF

Profit & Loss

Consolidated Figures in Rs. Crores / View Standalone

Mar 2012 Mar 2013 Mar 2022 Mar 2023 Mar 2024 TTM
97 109 230 234 248 341
82 89 193 185 198 290
Operating Profit 15 20 37 49 50 51
OPM % 15% 18% 16% 21% 20% 15%
1 1 -87 1 4 4
Interest 2 4 11 10 9 9
Depreciation 5 5 3 3 3 3
Profit before tax 9 12 -63 36 42 43
Tax % -1% 4% 6% 3% 5%
9 12 -67 35 40 41
EPS in Rs 5.75 7.34 -35.46 18.42 20.85 21.80
Dividend Payout % -0% -0% -6% 11% 10%
Compounded Sales Growth
10 Years: %
5 Years: %
3 Years: %
TTM: 4%
Compounded Profit Growth
10 Years: %
5 Years: %
3 Years: %
TTM: 1%
Stock Price CAGR
10 Years: 5%
5 Years: -8%
3 Years: -13%
1 Year: -2%
Return on Equity
10 Years: %
5 Years: %
3 Years: %
Last Year: 6%

Balance Sheet

Consolidated Figures in Rs. Crores / View Standalone

Mar 2012 Mar 2013 Mar 2022 Mar 2023 Mar 2024
Equity Capital 16 16 19 19 19
Reserves 30 41 523 554 591
11 19 93 105 110
63 82 105 114 160
Total Liabilities 120 158 739 793 880
21 38 245 244 249
CWIP -0 -0 -0 -0 -0
Investments 1 -0 5 5 6
99 121 490 543 625
Total Assets 120 158 739 793 880

Cash Flows

Consolidated Figures in Rs. Crores / View Standalone

Mar 2012 Mar 2013 Mar 2022 Mar 2023 Mar 2024
17 38 75
-20 -3 -27
-22 -2 -8
Net Cash Flow -25 34 39

Ratios

Consolidated Figures in Rs. Crores / View Standalone

Mar 2012 Mar 2013 Mar 2022 Mar 2023 Mar 2024
Debtor Days 47 70 136 152 139
Inventory Days 587 667 4,388
Days Payable 146 239 586
Cash Conversion Cycle 487 499 136 3,954 139
Working Capital Days 109 122 573 577 497
ROCE % 24% 7% 7%

Shareholding Pattern

Numbers in percentages

Sep 2021Dec 2021Mar 2022Jun 2022Sep 2022Dec 2022Mar 2023Jun 2023Sep 2023Dec 2023Mar 2024Jun 2024
41.03% 41.03% 41.05% 41.07% 45.59% 45.59% 45.59% 45.59% 45.59% 45.59% 45.59% 45.59%
0.01% 0.04% 0.07% 0.11% 0.01% 0.15% 0.13% 0.07% 0.22% 0.32% 0.27% 0.21%
9.38% 7.17% 4.85% 4.62% 4.62% 4.62% 4.62% 4.62% 4.37% 4.37% 4.37% 4.37%
49.58% 51.76% 54.02% 54.20% 49.77% 49.62% 49.65% 49.71% 49.81% 49.72% 49.76% 49.80%
No. of Shareholders 33,27233,92635,61035,48435,47034,74933,96033,50234,36534,26335,13235,834

* The classifications might have changed from Sep'2022 onwards. The new XBRL format added more details from Sep'22 onwards.

Classifications such as banks and foreign portfolio investors were not available earlier. The sudden changes in FII or DII can be because of these changes.

Click on the line-items to see the names of individual entities.

Documents

Concalls